In an immunohistochemical study, four (5.1%) endometrial endometrioid carcinomas were positive for GATA3, and the expression of this marker was observed in 13 (12.9%) ovarian and 1 (11.1%) endocervical adenocarcinoma. Here, GATA3 is linked to endocervical adenocarcinoma.